Ving Tsun Martial Exercise for Older Adults

October 18, 2017 updated by: Shirley S.M. Fong, The University of Hong Kong

Exercise is Medicine and Community Wellness - A Ving Tsun Martial Exercise Programme for Community-dwelling Older Adults

Objectives: To evaluate the effects of a Ving Tsun (VT) reactive balance training programme on reactive balance control, muscle strength, balance confidence and falls in community-dwelling older adults.

Hypothesis: The VT group subjects will have improved post-training reactive balance control, muscle strength, balance confidence and fall incidence outcomes than the active controls.

Design and subjects: In this prospective, randomised, single-blinded controlled trial, approximately 114 healthy seniors (55-70 years old) will be randomly assigned to either the VT group (n~57) or control group (n~57). Interventions: Subjects in the VT group will receive VT reactive balance training (3 hours/week) for 3 months, whereas subjects in the control group will receive no VT training but will jog 3 hours/week during the intervention period.

Study instruments and outcomes: Primary outcome measures: reactive balance control, as indicated by lower extremity muscle activation onset latency; hip and ankle strategies and centre of pressure movements will be measured by electromyography, electrogoniometry and a force platform, respectively. Secondary outcome measures: knee muscle strength, balance confidence and fall history will be assessed by an isokinetic dynamometer, Activities-specific Balance Confidence Scale (Chinese) and interviews, respectively (pre-, post- and follow-up measurements).

Data analysis: Data will be analysed using repeated-measures analysis of (co)variance followed by post-hoc tests, as appropriate (alpha = 0.05).

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Objectives:

To evaluate the effects of a Ving Tsun (VT) martial exercise programme on reactive balance control, lower limb muscle strength, balance confidence and falls in community-dwelling older adults.

Study design:

This will be a prospective, non-randomised and controlled intervention trial.

Subjects:

Approximately 40 healthy older adults will be recruited from elderly community centres by convenience sampling through poster advertising. Eligible subjects will be allocated to either the VT group (n ≈ 20) or control group (n ≈ 20).

Outcome measurements:

All subjects will be assessed before the intervention (baseline tests) and shortly after the 3-month intervention (post-tests). All subjects, regardless of group assignment, will undergo the following baseline tests and post-tests in random order.

Primary outcome measures Reactive balance control including lower extremity muscle activation onset latency and centre of pressure movement in standing.

Secondary outcome measures Lower extremity (knee) muscle strength, balance confidence and fall history.

Data analysis:

Data will be analysed using repeated-measures analysis of (co)variance followed by post-hoc tests, as appropriate (alpha = 0.05).

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hong Kong, Hong Kong
        • University of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

51 years to 66 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. aged between 55 and 70 years,
  2. able to ambulate independently,
  3. an Abbreviated Mental Test (Hong Kong version) score > 7 and
  4. able to follow commands and communicate with others.

Exclusion Criteria:

  1. unstable medical condition (e.g. uncontrolled hypertension),
  2. recent injury that may affect test performance,
  3. history of fragility fractures,
  4. significant musculoskeletal disorder (e.g. frozen shoulder),
  5. sensorimotor disorder that may affect balance performance,
  6. significant neurological disorder (e.g. stroke),
  7. cardiopulmonary disease (e.g. chronic obstructive pulmonary disease),
  8. cognitive disorders,
  9. regular engagement in sports or martial arts training (e.g. Tai Chi) and
  10. too frail to participate in VT intervention.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ving Tsun (VT) group
Participants in the VT group will receive VT exercise intervention for 12 weeks.
The VT training regimen is designed to improve reactive balance control, lower extremity muscle strength and balance confidence in the elderly. It comprises 9 VT sticking-hand drills that must be practised with a partner. Participants will be trained to respond rapidly to upper body perturbations and to maintain body balance. Those joined the VT training group will attend a one-hour supervised VT training session at an elderly community centre 2 times per week for 12 weeks.
No Intervention: Control group
No intervention but can continue daily activities.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lower extremity muscle activation onset latency
Time Frame: 3 months
Lower extremity muscle activation onset latency in response to postural preturbation will be measured using surface electromyography.
3 months
Centre of pressure movement in standing
Time Frame: 3 months
Centre of pressure movement in standing will be measured using a force platform.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee maximum muscle strength
Time Frame: 3 months
Knee maximum muscle strength will be measured by an isokinetic dynamometer.
3 months
Balance confidence
Time Frame: 3 months
Balance confidence will be evaluated using the Activities-specific Balance Confidence Scale. Participants will be asked to rate on an 11-point scale ranging from 0 (no balance confident) to 100 (completely confident) for completing 16 daily activities while maintaining body balance. The mean of the total item score (0-100) will be used for analysis. Higher scores indicate better balance confidence.
3 months
Fall history
Time Frame: 3 months
The number of falls and fall related injuries will be obtained through interviews.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

November 1, 2017

Primary Completion (Anticipated)

October 9, 2020

Study Completion (Anticipated)

October 9, 2020

Study Registration Dates

First Submitted

October 9, 2017

First Submitted That Met QC Criteria

October 18, 2017

First Posted (Actual)

October 23, 2017

Study Record Updates

Last Update Posted (Actual)

October 23, 2017

Last Update Submitted That Met QC Criteria

October 18, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1602061

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Old Age; Atrophy

Subscribe